Drug target identified for chemotherapy-resistant ovarian, breast cancer
Researchers at the School of Medicine may have found a path toward improving the effectiveness of chemotherapy in people with breast or ovarian cancer caused by defects in one of the BRCA genes. The researchers identified a pair of genes that operate in parallel to BRCA and may increase susceptibility to chemotherapy drugs.
Novel imaging technology may help reduce biopsies for breast tumors
Scientists at Washington University in St. Louis plan to use a new imaging technique to get a better look at breast tumors and reduce unnecessary biopsies.
Making sense, pictures of medical data
A picture may be worth a thousand words, but what if you don’t want a whole essay? A computer engineer at Washington University in St. Louis is building visualizations to clarify and condense health risk data for patients.
Uninsured breast cancer patients more likely to die
Uninsured women with breast cancer were nearly 2.6 times more likely to have a late stage diagnosis than cancer patients who were insured, finds a new study from Kimberly Johnson, associate professor at the Brown School.
Detecting, diagnosing women’s cancers in new ways
The National Institutes of Health has awarded a Washington University in St. Louis faculty member in the School of Engineering & Applied Science a total of $1.3 million to study new imaging techniques designed to better fight breast and ovarian cancers.
New study shows breast tumors evolve in response to hormone therapy
Researchers at The McDonnell Genome Institute at the School of Medicine have co-led a study on breast tumors — before and after hormone reduction therapy. It reveals the extreme genetic complexity of these tumors and the variety of responses that are possible to estrogen-deprivation treatments.
Delaying radiation therapy for women with very early breast cancer ups recurrence
Delaying radiation therapy too long after surgery significantly increases the risk of recurrent tumors in women treated for very early, or what is referred to as “stage 0,” breast cancer, according to new research at the School of Medicine.
Surviving breast cancer: Younger women face bigger hurdles
Breast cancer takes a daunting toll on all women, but it hits younger women especially hard, finds a new study from the Brown School. Women aged 18-44 with a history of breast cancer reported a lower health-related quality of life than older survivors, highlighting the impact of breast cancer on the physical and mental health of younger women.
Study uncovers inherited genetic susceptibility across 12 cancer types
In a new analysis, researchers at the School of Medicine have shed light on the hereditary elements across 12 cancer types — showing a surprising inherited component to stomach cancer and providing some needed clarity on the consequences of certain types of mutations in well-known breast cancer susceptibility genes BRCA1 and BRCA2.
Vitamin D relieves joint, muscle pain for breast cancer patients
High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis.
View More Stories